Key Details
Annual ROE
1.28%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Nov 09, 2023Recent annual earnings:
Mar 15, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
Feb 01, 2023Analyst ratings
Recent major analysts updates
24 June '21 HC Wainwright & Co.
Neutral02 June '21 Piper Sandler
Neutral18 Feb '21 HC Wainwright & Co.
Buy21 Dec '20 Piper Sandler
OverweightScreeners with LMNL included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Liminal BioSciences doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
Liminal (LMNL) Up 40% on Buyout Offer From Majority Shareholder
LMNL
Zacks Investment Research13 July 2023
If the minority shareholders of Liminal BioSciences (LMNL) accept the buyout offer, they will receive $8.50 per share. This offer is a dollar more than the initial proposal received by management in April.
Liminal BioSciences stock rockets on take-private deal with a fund managed by Thomvest Asset Management
LMNL
Market Watch12 July 2023
Liminal BioSciences Inc. LMNL, -1.33% stock is rallying 41.7% in premarket trades on Wednesday after the company said it agreed to go private at a price of $8.50 a share. Structured Alpha LP, a fund managed by Thomvest Asset Management Ltd.
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
LMNL
InvestorPlace05 April 2023
Liminal Biosciences (NASDAQ: LMNL ) stock is taking off on Wednesday as investors react to the biopharmaceutical company getting an unsolicited transaction proposal. According to a press release from the company, Structured Alpha LP is seeking to acquire Liminal Biosciences for $7.50 per share.
Liminal Biosciences' stock soars 91% after getting takeover offer that's more than double its price
LMNL
Market Watch05 April 2023
Liminal Biosciences Inc.'s stock LMNL, -4.23% soared 91% in premarket trade Wednesday, after the company said it's received an unsolicited takeover offer of $7.50 a share from Structured Alpha LP. That company already owns 64% of the outstanding stock and is now bidding for the rest.
FAQ
- What is the primary business of Liminal BioSciences?
- What is the ticker symbol for Liminal BioSciences?
- Does Liminal BioSciences pay dividends?
- What sector is Liminal BioSciences in?
- What industry is Liminal BioSciences in?
- What country is Liminal BioSciences based in?
- When did Liminal BioSciences go public?
- Is Liminal BioSciences in the S&P 500?
- Is Liminal BioSciences in the NASDAQ 100?
- Is Liminal BioSciences in the Dow Jones?
- When was Liminal BioSciences's last earnings report?
- When does Liminal BioSciences report earnings?
What is the primary business of Liminal BioSciences?
Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company is developing LMNL6511, a selective antagonist for the G-protein coupled receptor 84, is expected to commence a Phase 1 clinical trial. It is also developing potential OXER1 antagonists and GPR40 agonists, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.
What is the ticker symbol for Liminal BioSciences?
The ticker symbol for Liminal BioSciences is NASDAQ:LMNL
Does Liminal BioSciences pay dividends?
No, Liminal BioSciences does not pay dividends
What sector is Liminal BioSciences in?
Liminal BioSciences is in the Healthcare sector
What industry is Liminal BioSciences in?
Liminal BioSciences is in the Biotechnology industry
What country is Liminal BioSciences based in?
Liminal BioSciences is headquartered in Canada
When did Liminal BioSciences go public?
Liminal BioSciences's initial public offering (IPO) was on 18 December 2009
Is Liminal BioSciences in the S&P 500?
No, Liminal BioSciences is not included in the S&P 500 index
Is Liminal BioSciences in the NASDAQ 100?
No, Liminal BioSciences is not included in the NASDAQ 100 index
Is Liminal BioSciences in the Dow Jones?
No, Liminal BioSciences is not included in the Dow Jones index
When was Liminal BioSciences's last earnings report?
Liminal BioSciences's most recent earnings report was on 9 November 2023
When does Liminal BioSciences report earnings?
The date for Liminal BioSciences's next earnings report has not been announced yet